Conference Coverage

VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?


 

AT THE INTERNATIONAL STROKE CONFERENCE

SAN DIEGO – After 6 months, Medtronic’s Reveal XT implant picked up atrial fibrillation in 8.6% of cryptogenic stroke patients. Standard monitoring found it in 1.4%, according to company data presented at the International Stroke Conference. Devices from Medtronic and other companies are going to make detection of asymptomatic atrial fibrillation more common, raising questions about when to intervene. Cardiologist Rod Passman, an investigator for the company, and neurologist Steven Greenberg shared their thoughts on the issue.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Fingolimod heart effects usually resolve within 6 hours
MDedge Neurology
Personalization declared route to improved AF care
MDedge Neurology
Undetected silent AF is present in 3% of 75-year-olds
MDedge Neurology
CHA2DS2-VASc score performs best in assessing atrial fibrillation stroke risk
MDedge Neurology
Anticoagulant edoxaban comparable with warfarin in atrial fib
MDedge Neurology
Novel Watchman antistroke device backed as warfarin equivalent
MDedge Neurology
Personalization keys vision of improved atrial fib care
MDedge Neurology
Cooling the resuscitated sudden dead
MDedge Neurology
New tools for stroke prediction in atrial fibrillation
MDedge Neurology
Continuous AF monitors raise questions about when to intervene
MDedge Neurology

Related Articles